GO
Loading...

Arena Surges on FDA Approval

Wednesday, 27 Jun 2012 | 5:15 PM ET

Shares of Arena Pharmaceuticals spiked on news the FDA approved its anti-obesity drug, with the Fast Money traders; and discussing how tomorrow's ruling on the health care reform could impact the biotech sector, with Mark Schoenebaum, ISI.